CHICAGO — During Venture Connect at HIMSS23 on Wednesday, Holly Maloney, managing director of General Catalyst, discussed responsible AI use in healthcare and what the company looks for in a startup when considering an investment.
“Over the last three to four years, we’ve put pen to paper of…
From: www.healthcareitnews.com – Read more
Will Expanding to Life Sciences Reverse AMD’s Stock Decline?
AMD announced its first life sciences collaboration with AI-based drug developer Absci, providing its hardware and software for Absci’s AI drug discovery. Despite AMD also
